We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $97.9B
1-Year Est. Return 20.73%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+19.48%
1 Year Est. Return
+20.73%
3 Year Est. Return
+127.31%
5 Year Est. Return
+136.48%
10 Year Est. Return
+1,577.48%
AUM
$103B
AUM Growth
+$15.6B
Cap. Flow
+$795M
Cap. Flow %
0.77%
Top 10 Hldgs %
46.61%
Holding
230
New
5
Increased
111
Reduced
74
Closed
4

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$388M
2
SPOT icon
Spotify
SPOT
+$356M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$273M
4
MSFT icon
Microsoft
MSFT
+$222M
5
W icon
Wayfair
W
+$205M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.47%
2 Healthcare 16.47%
3 Communication Services 15.64%
4 Technology 12.03%
5 Financials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACTG icon
201
Acacia Research
ACTG
$443M
$973K ﹤0.01%
365,820
WEC icon
202
WEC Energy
WEC
$35.2B
$896K ﹤0.01%
9,720
+420
+5% +$38.3K
ES icon
203
Eversource Energy
ES
$27.3B
$889K ﹤0.01%
10,450
+450
+5% +$37.4K
ED icon
204
Consolidated Edison
ED
$39.6B
$798K ﹤0.01%
8,820
+420
+5% +$37.6K
WIT icon
205
Wipro
WIT
$19.8B
$744K ﹤0.01%
396,978
+81,848
+26% +$154K
FOMX
206
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$730K ﹤0.01%
219,400
EXC icon
207
Exelon
EXC
$46.9B
$709K ﹤0.01%
21,801
+1,192
+6% +$38.6K
AEE icon
208
Ameren
AEE
$30.1B
$545K ﹤0.01%
+7,100
New +$539K
EW icon
209
Edwards Lifesciences
EW
$51.1B
$293K ﹤0.01%
3,768
BITA
210
DELISTED
Bitauto Holdings Limited
BITA
$249K ﹤0.01%
16,750
-37,742
-69% -$570K
ARI
211
Apollo Commercial Real Estate
ARI
$872M
$221K ﹤0.01%
12,100
MBT
212
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$214K ﹤0.01%
21,100
NLY icon
213
Annaly Capital Management
NLY
$17.1B
$167K ﹤0.01%
4,441
WPM icon
214
Wheaton Precious Metals
WPM
$56.2B
$158K ﹤0.01%
5,310
TRGP icon
215
Targa Resources
TRGP
$55.9B
$106K ﹤0.01%
2,599
HCAT icon
216
Health Catalyst
HCAT
$169M
$86K ﹤0.01%
2,492
AGIO icon
217
Agios Pharmaceuticals
AGIO
$1.89B
$82K ﹤0.01%
1,709
-1,081,985
-100% -$40.9M
MASI
218
DELISTED
Masimo
MASI
$69K ﹤0.01%
438
SWAV
219
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$39K ﹤0.01%
891
ALEC icon
220
Alector
ALEC
$167M
$36K ﹤0.01%
2,072
SAGE
221
DELISTED
Sage Therapeutics
SAGE
$35K ﹤0.01%
490
ABEV icon
222
Ambev
ABEV
$47.1B
$11K ﹤0.01%
2,458
-53
-2% -$235
EVH icon
223
Evolent Health
EVH
$349M
-1,084,001
Closed -$7.79M
SPB icon
224
Spectrum Brands
SPB
$2.1B
-335,706
Closed -$17.7M
ASLN
225
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
-10,467
Closed -$724K

Similar funds

Baillie Gifford & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Baillie Gifford & Co held 230 positions worth $103B, up 18% from $87.9B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.9%. Baillie Gifford & Co opened 5 new positions and exited 4, leaving the 230-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

  • Baillie Gifford & Co's largest Q4 2019 buy was LiveRamp: 803,200 shares worth $38.6M.
  • Baillie Gifford & Co added most to Alibaba in Q4 2019, an estimated $388M increase.
  • Baillie Gifford & Co's biggest Q4 2019 reduction was Baidu, cutting an estimated $499M.
  • Baillie Gifford & Co fully exited Spectrum Brands in Q4 2019, selling an estimated $17.7M.
  • Baillie Gifford & Co's ten largest holdings make up 47% of its $103B portfolio in Q4 2019.
  • Baillie Gifford & Co opened 5 new positions and closed 4 in Q4 2019.
  • Baillie Gifford & Co's portfolio value rose 18% quarter-over-quarter to $103B.

Based on Baillie Gifford & Co's 13F filing for Q4 2019, filed 10 Feb 2020.